Cutaneous inflammatory disorders.
Appleby
P
P
Boots Pharmaceuticals Research Department, Nottingham, UK.
Bowen
J G
JG
D000818:Animals; D002147:Calmodulin / Q000378:metabolism; D003872:Dermatitis / Q000378:metabolism / Q000503:physiopathology*; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins / Q000633:toxicity; D005456:Fluorescent Dyes / Q000633:toxicity; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D010081:Oxazolone / Q000633:toxicity; D010741:Phospholipases A / Q000378:metabolism; D010853:Picryl Chloride / Q000633:toxicity; D010972:Platelet Activating Factor / Q000502:physiology; D013861:Thiocyanates / Q000633:toxicity
D002147:Calmodulin; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007375:Interleukin-1; D010972:Platelet Activating Factor; D013861:Thiocyanates; D010081:Oxazolone; D010741:Phospholipases A; D016650:Fluorescein-5-isothiocyanate; D010853:Picryl Chloride